A profile of the cobas® TV/ MG test for the detection of Trichomonas vaginalis and Mycoplasma genitalium

References

• Rowley J, Vander Hoorn S, Korenromp E, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97(8):548–62P.
   PubMed Web of Science ®Google Scholar
• Johnson CL, Paulose-Ram R, Ogden CL, et al. National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Stat. 2013;2(161):1–24.
   Google Scholar
• Kelley SS, Borawski EA, Flocke SA, et al. The role of sequential and concurrent sexual relationships in the risk of sexually transmitted diseases among adolescents. J Adolesc Health. 2003;32(4):296–305.
   PubMed Web of Science ®Google Scholar
• Flagg EW, Meites E, Phillips C, et al. Prevalence of Trichomonas vaginalis among civilian, noninstitutionalized male and female population aged 14 to 59 years: United States, 2013 to 2016. Sex Transm Dis. 2019;46(10):e93–e6.
   PubMed Web of Science ®Google Scholar
• Manhart LE, Holmes KK, Hughes JP, et al. Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection. Am J Public Health. 2007;97(6):1118–1125.
   PubMed Web of Science ®Google Scholar
• Meites E, Gaydos CA, Hobbs MM, et al. A review of evidence-based care of symptomatic trichomoniasis and asymptomatic Trichomonas vaginalis infections. Clin Infect Dis. 2015;61(Suppl 8(suppl_8)):S837–48.
   PubMed Web of Science ®Google Scholar
• Kissinger P. Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues. BMC Infect Dis. 2015;15(1):307.
   PubMed Web of Science ®Google Scholar
• Van Der Pol B, Williams JA, Orr DP, et al. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J Infect Dis. 2005;192(12):2039–2044.
   PubMed Web of Science ®Google Scholar
• Silver BJ, Guy RJ, Kaldor JM, et al. Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis. Sex Transm Dis. 2014;41(6):369–376.
   PubMed Web of Science ®Google Scholar
• Trent M, Perin J, Butz A, et al. Clearance of Mycoplasma genitalium and Trichomonas vaginalis among adolescents and young adults with pelvic inflammatory disease: results from the TECH-N study. J Pediatr Adolesc Gynecol. 2018;31(2):217–218.
   Google Scholar
• Masha SC, Cools P, Sanders EJ, et al. Trichomonas vaginalis and HIV infection acquisition: a systematic review and meta-analysis. Sex Transm Infect. 2019;95(1):36–42.
   PubMed Web of Science ®Google Scholar
• Van Der Pol B, Kwok C, Pierre-Louis B, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis. 2008;197(4):548–554.
   PubMed Web of Science ®Google Scholar
• Mavedzenge SN, Pol BV, Cheng H, et al. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis. 2010;37(7):460–466.
   PubMed Web of Science ®Google Scholar
• McClelland RS, Sangare L, Hassan WM, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis. 2007;195(5):698–702.
   PubMed Web of Science ®Google Scholar
• Kissinger P, Adamski A. Trichomoniasis and HIV interactions: a review. Sex Transm Infect. 2013;89(6):426–433.
   PubMed Web of Science ®Google Scholar
• Quinlivan EB, Patel SN, Grodensky CA, et al. Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care. Sex Transm Dis. 2012;39(9):671–677.
   PubMed Web of Science ®Google Scholar
• Goje O, Munoz J, Nolte F, et al. Prevalence and clinical significance of Mycoplasma genitalium in gynecologic patients. J AIDS Clin Res. 2017; 8(5).
   Google Scholar
• Horner PJ, Martin DH. Mycoplasma genitalium infection in men. J Infect Dis. 2017;216(suppl_2):S396–S405.
   PubMed Web of Science ®Google Scholar
• Wiesenfeld HC, Manhart LE. Mycoplasma genitalium in women: current knowledge and research priorities for this recently emerged pathogen. J Infect Dis. 2017;216(suppl_2):S389–S95.
   PubMed Web of Science ®Google Scholar
• Latimer RL, Read TRH, Vodstrcil LA, et al. Clinical features and therapeutic response in women meeting criteria for presumptive treatment for pelvic inflammatory disease associated with Mycoplasma genitalium. Sex Transm Dis. 2019;46(2):73–79.
   PubMed Web of Science ®Google Scholar
• Mavedzenge SN, Van Der Pol B, Weiss HA, et al. The association between Mycoplasma genitalium and HIV-1 acquisition in African women. AIDS. 2012;26(5):617–624.
   PubMed Web of Science ®Google Scholar
• Bradshaw CS, Jensen JS, Waites KB. New horizons in Mycoplasma genitalium treatment. J Infect Dis. 2017;216(suppl_2):S412–S9.
   PubMed Web of Science ®Google Scholar
• Murray GL, Bradshaw CS, Bissessor M, et al. Increasing macrolide and fluoroquinolone resistance in Mycoplasma genitalium. Emerg Infect Dis. 2017;23(5):809–812.
   PubMed Web of Science ®Google Scholar
• Gaydos CA. #60;italic#62;Mycoplasma genitalium#60;/italic#62;: accurate diagnosis is necessary for adequate treatment. J Infect Dis. 2017;216(suppl_2):S406–S11.
   PubMed Web of Science ®Google Scholar
• Jensen JS, Cusini M, Gomberg M, et al. 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2016;30(10):1650–1656.
   PubMed Web of Science ®Google Scholar
• Workowski KA. Centers for disease control and prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis. 2015;61(Suppl 8(suppl 8)):S759–62.
   PubMed Web of Science ®Google Scholar
• Unemo M, Salado-Rasmussen K, Hansen M, et al. Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016. Clin Microbiol Infect. 2018;24(5):533–539.
   PubMed Web of Science ®Google Scholar
• Braam JF, van Marm S, Severs TT, et al. Sensitive and specific assay for the simultaneous detection of Mycoplasma genitalium and macrolide resistance-associated mutations. Eur J Clin Microbiol Infect Dis. 2018;37(11):2137–2144.
   PubMed Web of Science ®Google Scholar
• Choe H-S, Lee DS, Lee S-J, et al. Performance of Anyplex™ II multiplex real-time PCR for the diagnosis of seven sexually transmitted infections: comparison with currently available methods. Int J Infect Dis. 2013;17(12):e1134–e40.
   PubMed Web of Science ®Google Scholar
• Su JP, Tan LY, Garland SM, et al. Evaluation of the SpeeDx ResistancePlus MG diagnostic test for #60;italic#62;Mycoplasma genitalium#60;/italic#62; on the applied biosystems 7500 fast quantitative PCR platform. J Clin Microbiol. 2018;56(1):e01245–17.
   PubMed Web of Science ®Google Scholar
• De Baetselier I, Smet H, Vuylsteke B, et al. P1. 24 Mycoplasma genitalium and Trichomonas vaginalis detection in a cohort of men who have sex with men in belgium: evaluation of the diagenode s-diamgtv multiplex kit. BMJ Publishing Group Ltd; 2017: A53–A53.
   Google Scholar
• Le Roy C, Bébéar C, Pereyre S. Clinical evaluation of three commercial PCR assays for the detection of macrolide resistance in Mycoplasma genitalium. J Clin Microbiol. 2019. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Marlowe EM, Gohl P, Steidle M. et al. Trichomonas vaginalis detection in female specimens with cobas® TV/MG for use on the cobas® 6800/8800 systems. Eur J Microbiol Immunol. 2019;9(2):42–45.
   Web of Science ®Google Scholar
• Xiao L, Waites KB, Wang H, et al. Evaluation of a real-time PCR assay for detection of Mycoplasma genitalium and macrolide resistance-mediating mutations from clinical specimens. Diagn Microbiol Infect Dis. 2018;91(2):123–125.
   PubMed Web of Science ®Google Scholar
• Weger BO, Klein DA, Bowsher BL, et al. Measuring community prevalence of Trichomonas vaginalis infection to guide local screening practices: a process improvement project. Sex Transm Dis. 2019;46(2):e11–e3.
   PubMed Web of Science ®Google Scholar
• Schwebke J, Merriweather A, Massingale S, et al. Screening for Trichomonas vaginalis in a large high-risk population: prevalence among men and women determined by nucleic acid amplification testing. Sex Transm Dis. 2018;45(5):e23.
   PubMed Web of Science ®Google Scholar
• Field N, Clifton S, Alexander S, et al. Trichomonas vaginalis infection is uncommon in the British general population: implications for clinical testing and public health screening. Sex Transm Infect. 2018;94(3):226–229.
   PubMed Web of Science ®Google Scholar
• Bruni MP, da Silveira MF, Stauffert D, et al. Aptima Trichomonas vaginalis assay elucidates significant underdiagnosis of trichomoniasis among women in Brazil according to an observational study. Sex Transm Infect. 2019;95(2):129–132.
   PubMed Web of Science ®Google Scholar
• Tomas ME, Getman D, Donskey CJ, et al. Overdiagnosis of urinary tract infection and underdiagnosis of sexually transmitted infection in adult women presenting to an emergency department. J Clin Microbiol. 2015;53(8):2686–2692.
   PubMed Web of Science ®Google Scholar
• Sweeney E, Trembizki E, Bletchly C, et al. Levels of Mycoplasma genitalium antimicrobial resistance differ by both region and gender in the state of Queensland, Australia: implications for treatment guidelines. J Clin Microbiol. 2019;57(3):e01555–18.
   PubMed Web of Science ®Google Scholar
• Pinto-Sander N, Soni S. Mycoplasma genitalium infection. BMJ. 2019;367:l5820.
   PubMed Web of Science ®Google Scholar
• Getman D, Jiang A, O’Donnell M, et al. Mycoplasma genitalium prevalence, coinfection, and macrolide antibiotic resistance frequency in a multicenter clinical study cohort in the United States. J Clin Microbiol. 2016;54(9):2278–2283.
   PubMed Web of Science ®Google Scholar
• Sarier M. Prevalence of polymicrobial infection in urethritis. J Urol Surg. 2019;6(3):180–183.
   Web of Science ®Google Scholar